News | Proton Therapy | July 30, 2018

IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan

Pair of new proton therapy systems installed in just 12 months, equaling IBA’s shortest time to completion

IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan

July 30, 2018 – IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton therapy solution in Japan. The first installation took place at the Hokkaido Ohno Memorial Hospital in Sapporo and the other at the Narita Memorial Proton Center in Toyohashi. Both installations were successful, according to the company, as the Hokkaido Ohno Memorial Hospital installation took less than 12 months and the Narita Memorial Proton Center installation took less than 11 months.

Hokkaido Ohno Memorial Hospital expects to start treating its first patient in the coming weeks, whilst Narita Memorial Proton Center plans to start treatment in September 2018.

The single room Proteus One solution, installed and maintained by IBA, offers a truly compact intensity modulated proton therapy (IMPT) system. The unique open gantry environment is designed to facilitate the treatment workflow for radiation therapists and optimize the patient experience by providing a comfortable and soothing environment. Its compact design makes it easy to install, integrate, operate and finance.

Makoto Narita, M.D., chairman, Narita Memorial Hospital in Toyohashi added: “We were able to open the Proton Therapy Center in a very small space downtown thanks to the compact design of the Proteus One manufactured by IBA. This convenient location means that outpatient treatment emphasizing social life becomes possible. We will continue working together with IBA to provide the most advanced and patient-friendly proton therapy treatment available.”
 
For more information: www.iba-worldwide.com

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...